Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Average PT from Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received an average rating of “Hold” from the four analysts that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $4.00.

Separately, Weiss Ratings lowered Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a report on Monday, July 13th.

Institutional Investors Weigh In On Bioceres Crop Solutions

Institutional investors and hedge funds have recently bought and sold shares of the company. Jones Financial Companies Lllp grew its position in shares of Bioceres Crop Solutions by 3,535.8% during the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after buying an additional 5,339 shares in the last quarter. Bank of America Corp DE raised its holdings in shares of Bioceres Crop Solutions by 186.7% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of Bioceres Crop Solutions in the third quarter valued at about $40,000. Invesco Ltd. purchased a new stake in Bioceres Crop Solutions in the fourth quarter worth about $45,000. Finally, PDT Partners LLC lifted its stake in Bioceres Crop Solutions by 58.9% in the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after acquiring an additional 10,449 shares during the period. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Trading Down 3.8%

BIOX stock opened at $0.36 on Thursday. Bioceres Crop Solutions has a 12 month low of $0.30 and a 12 month high of $3.60. The firm’s 50-day moving average is $0.37 and its 200 day moving average is $0.52. The company has a market capitalization of $23.02 million, a PE ratio of -0.09 and a beta of 0.41. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.88 and a quick ratio of 0.70.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.11). The company had revenue of $39.40 million during the quarter, compared to analysts’ expectations of $54.50 million. Bioceres Crop Solutions had a negative net margin of 92.85% and a negative return on equity of 33.97%.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.